SEARCH SITE
VIRGINIA LAW PORTAL
- Code of Virginia
- Virginia Administrative Code
- Constitution of Virginia
- Charters
- Authorities
- Compacts
- Uncodified Acts
- RIS Users (account required)
SEARCHABLE DATABASES
- Bills & Resolutions
session legislation - Bill Summaries
session summaries - Reports to the General Assembly
House and Senate documents - Legislative Liaisons
State agency contacts
ACROSS SESSIONS
- Subject Index: Since 1995
- Bills & Resolutions: Since 1994
- Summaries: Since 1994
Developed and maintained by the Division of Legislative Automated Systems.
1995 SESSION
HB 1921 Routine component of prenatal care.
Introduced by: Marian Van Landingham | all patrons ... notes | add to my profiles
SUMMARY:
Routine component of prenatal care. Requires all practitioners rendering prenatal care to advise every pregnant woman, as a routine component of prenatal care, of the value of testing for HIV infection and to request each such pregnant woman to consent to testing for such infection. Compliance with Virginia's laws on HIV confidentiality, informed consent, test result disclosure conditions, and appropriate counseling requirements is required. Practitioners must counsel all HIV-positive pregnant women about the dangers to the fetus and the advisability of receiving treatment in accordance with the then current Centers for Disease Control recommendations. Any pregnant woman has the right to refuse consent to testing for HIV infection and for any recommended treatment. Documentation of such refusal shall be maintained in the patient's medical record.
This bill is a recommendation of the Joint Subcommittee Studying the Issues, Policies, and Programs Relating to Infection with Human Immunodeficiency Viruses and resulted from a recommendation of the Virginia Pediatrics Society and the Medical Society of Virginia. The professional associations' recommendation was initiated because a recent study of zidovudine (formerly known as AZT) treatment of certain pregnant HIV-infected women, i.e., women with no history of extensive antiviral therapy, indicated that the rate of in utero HIV transmission was reduced among the treated women from 25 to 30 percent to approximately 8 percent. Zidovudine is a highly toxic drug, however, causing severe reactions in some patients, for example, anemia. Further, the long-term effects of zidovudine on the fetus are unknown. Because research in this area is moving fast (other drugs are already being tested), the Joint Subcommittee recommendation relates to “the then current Centers for Disease Control recommendations” in order to accommodate new treatments without amending the statute.
FULL TEXT
- 01/20/95 House: Presented & ordered printed LD5832476 pdf
- 01/30/95 House: Printed as engrossed LD5832476-E pdf
- 02/14/95 House: Bill text as passed House and Senate (HB1921ER) pdf
- 03/21/95 Governor: Acts of Assembly Chapter text (CHAP0309) pdf
AMENDMENTS
HISTORY
- 01/20/95 House: Presented & ordered printed LD5832476
- 01/20/95 House: Referred to Committee on Health, Welfare and Institutions
- 01/24/95 House: Assigned to H. W. I. sub-committee: 1
- 01/26/95 House: Reported from H. W. I. w/amendment (22-Y 0-N)
- 01/27/95 House: Read first time
- 01/30/95 House: Read second time
- 01/30/95 House: Committee amendment agreed to
- 01/30/95 House: Engrossed by House as amended
- 01/30/95 House: Printed as engrossed LD5832476-E
- 01/31/95 House: Read third time and passed House (Block Vote) (98-Y 0-N)
- 01/31/95 House: VOTE: BLOCK VOTE PASSAGE (98-Y 0-N)
- 01/31/95 House: Communicated to Senate
- 02/01/95 Senate: Read first time
- 02/01/95 Senate: Referred to Committee on Education and Health
- 02/09/95 Senate: Reported from Education and Health (14-Y 0-N)
- 02/10/95 Senate: Constitutional reading dispensed (40-Y 0-N)
- 02/10/95 Senate: VOTE: CONST. READING DISPENSED (40-Y 0-N)
- 02/13/95 Senate: Read third time
- 02/13/95 Senate: Passed Senate (40-Y 0-N)
- 02/13/95 Senate: VOTE: PASSAGE (40-Y 0-N)
- 02/14/95 House: Bill text as passed House and Senate (HB1921ER)
- 02/20/95 House: Enrolled
- 02/20/95 House: Signed by Speaker
- 02/21/95 Senate: Signed by President
- 03/16/95 Governor: Approved by Governor-Chapter 309 (effective 7/1/95)
- 03/21/95 Governor: Acts of Assembly Chapter text (CHAP0309)